Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold, Silver & Bullion  :  Gold futures end modestly higher on Friday

05-May2018

Gold futures end modestly higher on Friday

Gold futures ended modestly higher on Friday as the US dollar weakened slightly due to softer-than-expected US job data. However, gains remained capped as the data was strong enough to support the case for more interest rate hikes. Rising interest rate makes gold less attractive to investors as it does not pay interest.

Gold futures for June delivery settled up by $2, or 0.2 percent, at $1,314.70 per ounce, on the Comex division of the New York Mercantile. While, spot gold was up by 0.2 percent to $1,314.23 per ounce.



Related News

View all news

Gold futures settle higher on weak dollar

Gold futures settled higher on Wednesday, rebounding from previous session's lowest finish. The yellow metal marked biggest one-day gain in nearly two weeks, as the dollar eased by 0.2 percent after hitting......

Gold futures end lower on Tuesday

Gold futures ended lower on Tuesday on the back of a strong dollar against some major basket of currencies. Besides, slightly easing worries about US-China trade disputes after the two countries resumed......

Gold futures end lower on Tuesday

Gold futures ended lower on Tuesday on the back of a strong dollar against some major basket of currencies. Besides, slightly easing worries about US-China trade disputes after the two countries resumed......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......